An antiallergic activity of disodium cromoglycate unrelated to mast cell activation.
The pharmacological effects of disodium cromoglycate (DSCG) were studied in rats during the development of reactions to various allergens or carrageenin. DSCG (10 mg/kg and 100 mg/kg, i.v.) showed pronounced inhibitory effects on type I and type III (passive Arthus) allergic reactions. An immunological degranulation of mast cells and a significant decrease in tissue histamine content were observed in type I allergic reactions but not in type III allergic reactions characterized by an apparent infiltration of neutrophils. An antihistaminic agent, promethazine (1 mg/kg, i.v.) was effective only against type I allergic reactions and totally ineffective against type III allergic reactions. Thus, the results obtained above strongly suggest that DSCG exhibits at least two mechanisms of antiallergic action; one is related to mediator release from mast cells and the other is unrelated to mast cell activation.
D000485:Allergens; D000818:Animals; D002351:Carrageenan; D004205:Cromolyn Sodium / Q000494:pharmacology*; D006634:Histamine H1 Antagonists; D006636:Histamine Release / Q000187:drug effects; D006968:Hypersensitivity, Delayed; D006969:Hypersensitivity, Immediate; D007106:Immune Sera; D007249:Inflammation; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D000485:Allergens; D006634:Histamine H1 Antagonists; D007106:Immune Sera; D002351:Carrageenan; D011398:Promethazine; D004205:Cromolyn Sodium